Advertisement
Screener

Mirion Technologies, Inc. (MIR) Spending and interest coverage

Mirion Technologies, Inc. (MIR) Spending and interest coverage

  • R&D / revenue · 12 months: Value 3.89%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 1.92%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months3.89%Research and development expense / revenue. Period ending 2026-06-30.

$39.90M ÷ $1.02B × 100 ≈ 3.89%

Stock-based compensation / revenue · 12 months1.92%Share-based compensation / revenue. Period ending 2026-06-30.

$19.70M ÷ $1.02B × 100 ≈ 1.92%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending39.90M USDResearch and Development Expense
Revenue1.02B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation19.70M USDShare-based Payment Arrangement, Noncash Expense
Operating income54.50M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$39.90M$1.02B$19.70M$54.50M(m)3.89%1.92%(m)(m)
2026-03-31$39.80M$981.00M$16.10M$46.50M(m)4.06%1.64%(m)(m)
2025-12-31$38.90M$925.40M$15.20M$51.50M(m)4.20%1.64%(m)(m)
2025-09-30$36.90M$902.30M$14.90M$55.00M(m)4.09%1.65%(m)(m)
2025-06-30$37.00M$886.00M$14.70M$46.00M(m)4.18%1.66%(m)(m)
2025-03-31$35.80M$870.20M$15.40M$38.40M(m)4.11%1.77%(m)(m)
2024-12-31$35.00M$860.80M$15.60M$24.80M(m)4.07%1.81%(m)(m)
2024-09-30$34.70M$836.90M$16.10M$9.20M(m)4.15%1.92%(m)(m)
2024-06-30$32.40M$821.30M$18.00M$-300.00K(m)3.94%2.19%(m)(m)
2024-03-31$32.00M$811.40M$20.00M$-13.20M(m)3.94%2.46%(m)(m)
2023-12-31$31.70M$800.90M$21.90M$-21.90M(m)3.96%2.73%(m)(m)
2023-09-30$31.70M$788.40M$24.70M$-197.20M(m)4.02%3.13%(m)(m)
2023-06-30$31.80M$758.10M$26.90M$-213.80M(m)4.19%3.55%(m)(m)
2023-03-31$30.80M$736.70M$29.40M$-277.80M(m)4.18%3.99%(m)(m)
2022-12-31$30.30M$717.80M$31.80M$-297.80M(m)4.22%4.43%(m)(m)
2022-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-10-19(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30$29.40M$611.60M$0.00$11.20M(m)4.81%0.00%(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30$15.90M$478.20M$200.00K$23.00M(m)3.32%0.04%(m)(m)
2019-06-30$14.00M$440.10M$100.00K$28.80M(m)3.18%0.02%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.